IVOMEC PLUS (IVERMECTIN AND CLORSULON) INJECTION [MERIAL, INC.]

IVOMEC PLUS (IVERMECTIN AND CLORSULON) INJECTION [MERIAL, INC.]
PDF | XML

NDC 50604-4747-1, 50604-4747-2, 50604-4747-3, 50604-4747-4
Set ID df300159-9001-497a-a027-e0e7b5a4f65f
Category OTC ANIMAL DRUG LABEL
Packager Merial, Inc.
Generic Name
Product Class
Product Number
Application Number NADA140833
  • SPL UNCLASSIFIED SECTION

    NADA 140-833, Approved by the FDA       

    67302, 67303, 67304, 67305

  • VETERINARY INDICATIONS

    For the effective treatment and control of internal parasites, including adult liver flukes, and external parasites.

    Consult your veterinarian for assistance in the diagnosis, treatment and control of parasitism.

  • INTRODUCTION

    The ability of IVOMEC® (ivermectin) to deliver internal and external parasite control has been proven in cattle markets around the world. Now, Merial combines ivermectin, the active ingredient of IVOMEC, with clorsulon, an effective adult flukicide. A single injection of IVOMEC Plus (ivermectin and clorsulon) offers all the benefits of IVOMEC plus control of adult Fasciola hepatica.

    The dosage level of clorsulon supplied by IVOMEC Plus is effective only against adult liver flukes (Fasciola hepatica).

  • PRODUCT DESCRIPTION

    IVOMEC Plus is a ready-to-use sterile solution containing 1% w/v ivermectin, 10% clorsulon, 40% glycerol formal, and propylene glycol, q.s. ad 100%. It is formulated to deliver the recommended dose level of 200 mcg ivermectin/kg and 2 mg clorsulon/kg given subcutaneously behind the shoulder at the rate of 1 mL per 110 lb (50 kg) body weight.

  • MODE OF ACTION

    Ivermectin is a member of the macrocyclic lactone class of endectocides which have a unique mode of action. Compounds of the class bind selectively and with high affinity to glutamate-gated chloride ion channels which occur in invertebrate nerve and muscle cells. This leads to an increase in the permeability of the cell membrane to chloride ions with hyperpolarization of the nerve or muscle cell, resulting in paralysis and death of the parasite. Compounds of this class may also interact with other ligand-gated chloride channels, such as those gated by the neurotransmitter gamma-aminobutyric acid (GABA).

    The margin of safety for compounds of this class is attributable to the fact that mammals do not have glutamate-gated chloride channels, the macrocyclic lactones have a low affinity for other mammalian ligand-gated chloride channels and they do not readily cross the blood-brain barrier. Clorsulon is rapidly absorbed into the circulating blood. Erythrocytes with bound drug as well as plasma are ingested by Fasciola hepatica. Adult Fasciola hepatica are killed by clorsulon because of inhibition of enzymes in the glycolytic pathway, which is their primary source of energy.

  • INDICATIONS

    IVOMEC Plus Injection is indicated for the effective treatment and control of the following parasites of cattle:

    Gastrointestinal Roundworms (adults and fourth-stage larvae):
    Ostertagia ostertagi (including inhibited O. ostertagi)
    O. lyrata
    Haemonchus placei
    Trichostrongylus axei
    T. colubriformis
    Cooperia oncophora
    C. punctata
    C. pectinata
    Bunostomum phlebotomum
    Nematodirus helvetianus (adults only)
    N. spathiger (adults only)
    Oesophagostomum radiatum
    Lungworms (adults and fourth-stage larvae):
    Dictyocaulus viviparus
    Liver Flukes:
    Fasciola hepatica (adults only)
    Cattle Grubs (parasitic stages):
    Hypoderma bovis
    H. lineatum
    Sucking Lice:
    Linognathus vituli
    Haematopinus eurysternus
    Solenopotes capillatus
    Mange Mites (cattle scab1):
    Psoroptes ovis (syn. P. communis var. bovis)
    Sarcoptes scabiei var. bovis


    1
    Ivermectin has been approved as a scabicide by USDA/APHIS. Federal regulations require that cattle infested with or exposed to scabies (i.e., infestations with Psoroptes ovis) be treated. Ivermectin when used according to label instructions meets this requirement. Treated cattle may be shipped interstate, but they must not be mixed with other cattle for 14 days following treatment. The federal regulations make no restriction on the movement of cattle not affected with or exposed to scabies. However, individual states have additional regulations to govern the interstate shipment of cattle and the regulatory veterinarian in the state of destination should be consulted for applicable regulations on the use of ivermectin in the control of scabies.

    Persistent Activity

    IVOMEC Plus Injection has been proved to effectively control infections and to protect cattle from reinfection with Dictyocaulus viviparus and Oesophagostomum radiatum for 28 days after treatment; Ostertagia ostertagi, Trichostrongylus axei and Cooperia punctata for 21 days after treatment; Haemonchus placei, and Cooperia oncophora for 14 days after treatment.

  • DOSAGE

    IVOMEC Plus should be given only by subcutaneous injection at a dose volume of 1 mL per 110 lb (50 kg) body weight. This volume will deliver 10 mg ivermectin and 100 mg clorsulon. For example:

    Body Weight
    (lb)
    Dose
    (mL)

    220

    2

    330

    3

    440

    4

    550

    5

    660

    6

    770

    7

    880

    8

    990

    9

    1100

    10

  • ADMINISTRATION

    IVOMEC Plus (ivermectin and clorsulon) Injection is to be given subcutaneously only. Animals should be appropriately restrained to achieve the proper route of administration. Use of a 16-gauge, 1/2" to 3/4" sterile needle is recommended. Inject the solution subcutaneously (under the skin) behind the shoulder (see illustration).

    Cattle Illustration

    Any single-dose syringe or standard automatic syringe equipment may be used with the 50 mL pack size. When using the 200 mL, 500 mL or 1000 mL pack size, use only automatic syringe equipment.

    Use sterile equipment and sanitize the injection site by applying a suitable disinfectant. Clean, properly disinfected needles should be used to reduce the potential for injection site infections.

    No special handling or protective clothing is necessary.

    The viscosity of the product increases in cool temperatures.

    Administering IVOMEC® Plus at temperatures of 5°C (41°F) or below may be difficult. Users can make dosing easier by warming both the product and injection equipment to about 15°C (59°F).

  • ANIMAL SAFETY

    In breeding animals (bulls and cows), ivermectin and clorsulon used at the recommended level had no effect on breeding performance.

  • WARNING

    NOT FOR USE IN HUMANS.
    Keep this and all drugs out of the reach of children.

    The Material Safety Data Sheet (MSDS) contains more detailed occupational safety information. To report adverse effects, obtain an MSDS or for assistance, contact Merial at 1-888-637-4251.

  • RESIDUE WARNING

    Do not treat cattle within 21 days of slaughter. Because a withdrawal time in milk has not been established, do not use in female dairy cattle of breeding age. A withdrawal period has not been established for this product in pre-ruminating calves. Do not use in calves to be processed for veal.

  • PRECAUTIONS

    Transitory discomfort has been observed in some cattle following subcutaneous administration. Soft-tissue swelling at the injection site has also been observed. These reactions have disappeared without treatment. Divide doses greater than 10 mL between two injection sites to reduce occasional discomfort or site reaction. Different injection sites should be used for other parenteral products.

    IVOMEC Plus Injection has been developed specifically for use in cattle only. This product should not be used in other animal species as severe adverse reactions, including fatalities in dogs, may result.

    For subcutaneous injection in cattle only.

    This product is not for intravenous or intramuscular use.

    Restricted Drug (California) - use only as directed.

    When to Treat Cattle with Grubs

    IVOMEC Plus effectively controls all stages of cattle grubs. However, proper timing of treatment is important. For most effective results, cattle should be treated as soon as possible after the end of the heel fly (warble fly) season.

    Destruction of Hypoderma larvae (cattle grubs) at the period when these grubs are in vital areas may cause undesirable host-parasite reactions including the possibility of fatalities. Killing Hypoderma lineatum when it is in the tissue surrounding the esophagus (gullet) may cause bloat; killing H. bovis when it is in the vertebral canal may cause staggering or paralysis. These reactions are not specific to treatment with IVOMEC Plus, but can occur with any successful treatment of grubs. Cattle should be treated either before or after stages of grub development. Consult your veterinarian concerning the proper time for treatment.

    Cattle treated with IVOMEC Plus after the end of the heel fly season may be retreated with ivermectin during the winter for internal parasites, mange mites or sucking lice, without danger of grub-related reactions. A planned parasite control program is recommended.

    Protect product from light.

    Environmental Safety

    Studies indicate that when ivermectin comes in contact with soil it readily and tightly binds to the soil and becomes inactive overtime. Free ivermectin may adversely affect fish and certain aquatic organisms. Do not permit water runoff from feedlots to enter lakes, streams or ponds. Do not contaminate water by direct application or by improper disposal of drug containers. Dispose of containers in an approved landfill or by incineration.

    As with other avermectins, ivermectin is excreted in the dung of treated animals and can inhibit the reproduction and growth of pest and beneficial insects that use dung as a source of food and for reproduction. The magnitude and duration of such effects are species and life-cycle specific.

    When used according to label directions, the product is not expected to have an adverse impact on populations of dung-dependent insects.

  • HOW SUPPLIED

    IVOMEC Plus Injection is available in four ready-to-use pack sizes:

    The 50 mL pack is a multiple-dose, rubber-capped bottle. Each bottle contains sufficient solution to treat 10 head of 550 lb (250 kg) cattle.

    The 200 mL pack is a soft, collapsible pack designed for use with automatic syringe equipment. Each pack contains sufficient solution to treat 40 head of 550 lb (250 kg) cattle.

    The 500 mL pack is a soft, collapsible pack designed for use with automatic syringe equipment. Each pack contains sufficient solution to treat 100 head of 550 lb (250 kg) cattle.

    The 1000 mL pack is a soft, collapsible pack designed for use with automatic syringe equipment. Each pack contains sufficient solution to treat 200 head of 550 lb (250 kg) cattle.

  • SPL UNCLASSIFIED SECTION

    IVOMEC and Cattle Head Logo are registered trademarks of Merial.

    Copyright © 2016 Merial. All Rights Reserved.

    Distributed by:
    Merial, Inc.
    Duluth, GA 30096 USA

    Made in Brazil

    Rev. 01/2016

    603003858

  • PRINCIPAL DISPLAY PANEL - 1000 mL Bottle Carton

    NADA 140-833, Approved by the FDA
    Product 67305

    ivomec®Plus
    (ivermectin and clorsulon)

    Injection for Cattle

    Treats 200–550 lb Cattle

    For the treatment and control of internal
    parasites, including adult liver flukes, and
    external parasites.

    1000 mL
    MERIAL

    PRINCIPAL DISPLAY PANEL - 1000 mL Bottle Carton
  • INGREDIENTS AND APPEARANCE
    IVOMEC PLUS 
    ivermectin and clorsulon injection
    Product Information
    Product TypeOTC ANIMAL DRUGItem Code (Source)NDC:50604-4747
    Route of AdministrationSUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    ivermectin (UNII: 8883YP2R6D) (ivermectin - UNII:8883YP2R6D) ivermectin10 mg  in 1 mL
    clorsulon (UNII: EG1ZDO6LRD) (clorsulon - UNII:EG1ZDO6LRD) clorsulon100 mg  in 1 mL
    Inactive Ingredients
    Ingredient NameStrength
    glycerol formal (UNII: 3L7GR2604E)  
    Propylene Glycol (UNII: 6DC9Q167V3)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:50604-4747-11 in 1 CARTON
    150 mL in 1 BOTTLE
    2NDC:50604-4747-21 in 1 CARTON
    2200 mL in 1 BOTTLE
    3NDC:50604-4747-31 in 1 CARTON
    3500 mL in 1 BOTTLE
    4NDC:50604-4747-41 in 1 CARTON
    41000 mL in 1 BOTTLE
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    NADANADA14083310/01/1990
    Labeler - Merial, Inc. (799641006)

Related Drugs